Stop codon insertion restores the particle formation ability of hepatitis B virus core-hantavirus nucleocapsid protein fusions

Intervirology

Volumn 45, Issue 4-6, 2002, Pages 340-349

  Kazaks, Andris ^a   Lachmann, Sylvie ^b   Koletzki, Diana ^b   Petrovskis, Ivars ^a   Dislers, Andris ^a   Ose, Velta ^a   Skrastina, Dace ^a   Gelderblom, Hans R ^c   Lundkvist, Åke ^d,e   Meisel, Helga ^b   Borisova, Galina ^a   Krüger, Detlev H ^b   Pumpens, Paul ^a   Ulrich, Rainer ^b  

^a UNIVERSITY OF LATVIA   (Latvia)

^b HUMBOLDT UNIVERSITY   (Germany)

^c ROBERT KOCH INSTITUTE   (Germany)

^d KAROLINSKA INSTITUTE   (Sweden)

^e SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

Epitopes; Hantavirus; Mosaic hepatitis B virus core particles; Nucleocapsid protein; Virus like particles

Indexed keywords

AMINO ACID; HYBRID PROTEIN; NUCLEOCAPSID PROTEIN; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ANTIBODY RESPONSE; ANTIGENICITY; CONFERENCE PAPER; CONTROLLED STUDY; HANTAVIRUS; HEPATITIS B VIRUS; HYDROPHOBICITY; IMMUNIZATION; NONHUMAN; PRIORITY JOURNAL; STOP CODON;

ANIMALS; BASE SEQUENCE; CODON, TERMINATOR; HEPATITIS B CORE ANTIGENS; HEPATITIS B VIRUS; IMMUNIZATION; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; NUCLEOCAPSID; NUCLEOCAPSID PROTEINS; RECOMBINANT FUSION PROTEINS; VIRION;

ESCHERICHIA COLI; HANTAVIRUS; HEPATITIS B VIRUS; PUUMALA VIRUS;

EID: 0036983211     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000067927     Document Type: Conference Paper

References (41)

1. Plyusnin A, Morzunov SP: Virus evolution and genetic diversity of hantaviruses and their rodent hosts. Curr Top Microbiol Immunol 2001;256:47-75.
2. Krüger DH, Ulrich R, Lundkvist Å: Hantavirus infections and their prevention. Microbes Infect 2001;3:1129-1144.
3. Chu Y-K, Jennings GB, Schmaljohn CS: A vaccinia virus-vectored Hantaan virus vaccine protects hamsters from challenge with Hantaan and Seoul virus but not Puumala virus. J Virol 1995;69:6417-6423.
4. de Carvalho Nicacio C, Gonzalez Della Valle M, Padula P, Björling E, Plyusnin A, Lundkvist Å: Cross-protection against challenge with Puumala virus after immunization with nucleocapsid proteins from different hantaviruses. J Virol 2002;76:6669-6677.
5. Schmaljohn CS, Chu Y-K, Schmaljohn AL, Dalrymple JM: Antigenic subunits of Hantaan virus expressed by baculovirus and vaccinia virus recombinants. J Virol 1990;64:3162-3170.
6. Schmaljohn C, Kamrud K, Hooper J: Recombinant DNA vaccines for hantaviruses; in Saluzzo JF, Dodet B (eds): Factors in the Emergence and Control of Rodent-Borne Viral Diseases (Hantaviral and Arenaviral Diseases). Amsterdam, Elsevier, 1999, pp 163-173.
7. Xu X, Ruo SL, McCormick JB, Fisher-Hoch SP: Immunity to hantavirus challenge in Meriones unguiculatus induced by vaccinia-vectored viral proteins. Am J Trop Med Hyg 1992;47:397-404.
8. Kamrud KI, Hooper JW, Elgh F, Schmaljohn CS: Comparison of the protective efficacy of naked DNA, DNA-based Sindbis replicon and packaged Sindbis replicon vectors expressing hantavirus structural genes in hamsters. Virology 1999;263:209-219.
9. Hooper JW, Kamrud KI, Elgh F, Custer D, Schmaljohn CS: DNA vaccination with hantavirus M segments elicits neutralizing antibodies and protects against Seoul virus infection. Virology 1999;255:269-278.
10. Bucht G, Brus Sjölander K, Eriksson S, Lindgren L, Lundkvist Å, Elgh F: Modifying the cellular transport of DNA-based vaccines alters the immune response to hantavirus nucleocapsid protein. Vaccine 2001;19:3820-3829.
11. Lundkvist Å, Kallio-Kokko H, Brus Sjölander K, Lankinen H, Niklasson B, Vaheri A, Vapalahti O: Characterization of Puumala virus nucleocapsid protein: Identification of B-cell epitopes and domains involved in protective immunity. Virology 1996;216:397-406.
12. Dargeviciute A, Brus Sjölander K, Sasnauskas K, Krüger DH, Meisel H, Ulrich R, Lundkvist Å: Yeast-expressed Puumala hantavirus nucleocapsid protein induces protection in a bank vole model. Vaccine 2002;20:3523-3531.
13. Ulrich R, Nassal M, Meisel H, Krüger DH: Core particles of hepatitis B virus as carrier for foreign epitopes. Adv Virus Res 1998;50:141-182.
14. Pumpens P, Grens E: HBV core particles as a carrier for B cell/T cell epitopes. Intervirology 2001;44:98-114.
15. Ulrich R, Lundkvist Å, Meisel H, Koletzki D, Brus Sjölander K, Gelderblom HR, Borisova G, Schnitzler P, Darai G, Krüger DH: Chimaeric HBV core particles carrying a defined segment of Puumala hantavirus nucleocapsid protein evoke protective immunity in an animal model. Vaccine 1998;16:272-280.
16. Koletzki D, Lundkvist Å, Brus Sjölander K, Gelderblom HR, Niedrig M, Meisel H, Krüger DH, Ulrich R: Puumala (PUU) hantavirus strain differences and insertion positions in the hepatitis B virus core antigen influence B-cell immunogenicity and protective potential of core-derived particles. Virology 2000;276:364-375.
17. Brown AL, Francis MJ, Hastings GZ, Parry NR, Barnett PV, Rowlands DJ, Clarke BE: Foreign epitopes in immunodominant regions of hepatitis B core particles are highly immunogenic and conformationally restricted. Vaccine 1991;9:595-601.
18. Schödel F, Moriarty AM, Peterson DL, Zheng J, Hughes JL, Will H, Leturcq DJ, McGee JS, Milich DR: The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity. J Virol 1992;66:106-114.
19. Borisova G, Borschukova Wanst O, Mezule G, Skrastina D, Petrovskis I, Dislers A, Pumpens P, Grens E: Spatial structure and insertion capacity of immunodominant region of hepatitis B core antigen. Intervirology 1996;39:16-22.
20. Ulrich R, Koletzki D, Lachmann S, Lundkvist Å, Zankl A, Kazaks A, Kurth A, Gelderblom HR, Borisova G, Meisel H, Krüger DH: New chimeric hepatitis B virus core particles carrying hantavirus (serotype Puumala) epitopes: Immunogenicity and protection against virus challenge. J Biotechnol 1999;73:141-153.
21. Koletzki D, Zankl A, Gelderblom HR, Meisel H, Dislers A, Borisova G, Pumpens P, Krüger DH, Ulrich R: Mosaic hepatitis B virus core particles allow insertion of extended foreign protein segments. J Gen Virol 1997;78:2049-2053.
22. Ulrich R, Borisova GP, Gren E, Berzin I, Pumpen P, Eckert R, Ose V, Siakkou H, Gren EJ, von Baehr R, Krüger DH: Immunogenicity of recombinant core particles of hepatitis B virus containing epitopes of human immunodeficiency virus 1 core antigen. Arch Virol 1992;126:321-328.
23. Cifire F: Expression und immunologische Charakterisierung des Nukleokapsidproteins vom Hantavirusisolat Vranica; PhD thesis, Free University Berlin, 1997.
24. Smiley BK, Minion FC: Enhanced readthrough of opal (UGA) stop codons and production of Mycoplasma pneumoniae P1 epitopes in Escherichia coli. Gene 1993;134:33-40.
25. Lundkvist Å, Meisel H, Koletzki D, Lankinen H, Cifire F, Geldmacher A, Sibold C, Gött P, Vaheri A, Krüger DH, Ulrich R: Mapping of B-cell epitopes in the nucleocapsid protein of Puumala hantavirus. Viral Immunol 2002;15:177-192.
26. Lundkvist Å, Niklasson B: Bank vole monoclonal antibodies against Puumala virus envelope glycoproteins: Identification of epitopes involved in neutralization. Arch Virol 1992;126:93-105.
27. Lundkvist Å, Vapalahti O, Plyusnin A, Brus Sjölander K, Niklasson B, Vaheri A: Characterization of Tula virus antigenic determinants defined by monoclonal antibodies raised against baculovirus-expressed nucleocapsid protein. Virus Res 1996;45:29-44.
28. Sibold C, Meisel H, Lundkvist Å, Schulz A, Cifire F, Ulrich R, Kozuch O, Labuda M, Krüger DH: Simultaneous occurrence of Dobrava, Puumala, and Tula hantaviruses in Slovakia. Am J Trop Med Hyg 1999;61:409-411.
29. Neirynck S, Deroo T, Saelens X, Vanlandschoot P, Jou WM, Fiers W: A universal influenza A vaccine based on the extracellular domain of the M2 protein. Nat Med 1999;5:1157-1163.
30. Schödel F, Wirtz R, Peterson D, Hughes J, Warren R, Sadoff J, Milich D: Immunity to malaria elicited by hybrid hepatitis B virus core particles carrying circumsporozoite protein epitopes. J Exp Med 1994;180:1037-1046.
31. Elgh F, Lundkvist Å, Alexeyev OA, Wadell G, Juto P: A major antigenic domain for the human humoral response to Puumala virus nucleocapsid protein is located at the amino-terminus. J Virol Methods 1996;59:161-172.
32. Gött P, Zöller L, Darai G, Bautz EK: A major antigenic domain of hantaviruses is located on the aminoproximal site of the viral nucleocapsid protein. Virus Genes 1997;14:31-40.
33. Jenison S, Yamada T, Morris C, Anderson B, Torrez-Martinez N, Keller N, Hjelle B: Characterization of human antibody responses to four corners hantavirus infections among patients with hantavirus pulmonary syndrome. J Virol 1994;68:3000-3006.
34. Gött P, Stohwasser R, Schnitzler P, Darai G, Bautz EKF: RNA binding of recombinant nucleocapsid proteins of hantaviruses. Virology 1993;194:332-337.
35. Milich DR, Schödel F, Hughes JL, Jones JE, Peterson DL: The hepatitis B virus core and e antigens elicit different Th cell subsets: Antigen structure can affect Th cell phenotype. J Virol 1997;71:2192-2201.
36. Preikschat P, Kazaks A, Dishlers A, Pumpens P, Krüger DH, Meisel H: Interaction of wild-type and naturally occurring deleted variants of hepatitis B virus core polypeptides leads to formation of mosaic particles. FEBS Lett 2000;478:127-132.
37. Koletzki D, Biel SS, Meisel H, Nugel E, Gelderblom HR, Krüger DH, Ulrich R: HBV core particles allow the insertion and surface exposure of the entire potentially protective region of Puumala hantavirus nucleocapsid protein. Biol Chem 1999;380:325-333.
38. Kratz PA, Böttcher B, Nassal M: Native display of complete foreign protein domains on the surface of hepatitis B virus capsids. Proc Natl Acad Sci USA 1999;96:1915-1920.
39. Skrivelis V, Steinberg Y, Bichko V, Gren E, Tsimanis A: The structure of the variable regions of mouse monoclonal antibodies to hepatitis B virus core antigen. Scand J Immunol 1993;37:637-643.
40. Pushko P, Sällberg M, Borisova G, Ruden U, Bichko V, Wahren B, Pumpens P, Magnius L: Identification of hepatitis B virus core protein regions exposed or internalized at the surface of HBcAg particles by scanning with monoclonal antibodies. Virology 1994;202:912-920.
41. Borisova GP, Kalis IV, Pushko PM, Tsibinogin VV, Loseva VJ, Ose VP, Stankevica EI, Dreimane AJ, Snikere DJ, Grinstein EE, Pumpen PP, Gren EJ: Genetically engineered mutants of the core antigen of the human hepatitis B virus preserving the ability for native self-assembly (in Russian). Dokl Akad Nauk SSSR 1988;298:1474-1478.